Lungs News and Research

RSS

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Accuray Incorporated and Lancaster General Health announced today that the first commercially available InCise Multileaf Collimator (MLC) for the CyberKnife M6 System has been received by Lancaster.

24 Feb 2015

Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing

Agena Bioscience today released the MassARRAY 24-Well System for mass spectrometry-based genetic analysis, adding to its existing MassARRAY portfolio. The new 24-well format is tailored to smaller clinical testing laboratories requiring modest sample throughput, reduced initial hardware costs, and reduced time to result.

24 Feb 2015

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

According to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Acute Lymphoblastic Leukemia (ALL), the treatment approach to ALL is one of the most complex and intensive programs in cancer therapy.

24 Feb 2015

Boehringer Ingelheim presents Phase III data for tiotropium at 2015 AAAAI Annual Meeting

Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat inhaler from five Phase III trials from the UniTinA-asthma program at the 2015 American Academy of Allergy, Asthma & Immunology Annual Meeting in Houston, Texas.

24 Feb 2015

Tobacco smoke exposure common among children with bronchopulmonary dysplasia

Public health experts have long known that tobacco smoke exposure (TSE) can be harmful for children with bronchopulmonary dysplasia, a lung disease that often accompanies premature birth.

24 Feb 2015

Finding opens avenues of research toward precision treatments to boost life expectancy for CF patients

Mutation of one gene is all it takes to get cystic fibrosis (CF), but disease severity depends on many other genes and proteins. For the first time, researchers at the UNC School of Medicine have identified genetic pathways - or clusters of genes - that play major roles in why one person with CF might never experience the worse kinds of symptoms while another person will battle severe airway infection for a lifetime.

23 Feb 2015

Researchers develop targeted approach that allows muscle to burn more energy

What started as an evolutionary protection against starvation has become a biological "bad joke" for people who need to lose weight. The human body doesn't distinguish between dieting and possible starvation, so when there is a decrease in calories consumed, human metabolism increases its energy efficiency and weight loss is resisted.

23 Feb 2015

MD Anderson awarded more than $22 million in research grants from CPRIT

The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention.

21 Feb 2015

Rush University Medical Center earns three-star rating for lung cancer surgery program

Surgery to remove localized tumors is the only reliable way to cure lung cancer, the most prevalent cause of cancer-related deaths in both men and women. The most common operation performed to remove these cancers is a lobectomy (removal of an anatomic portion of lung). Thoracic surgeons at Rush University Medical Center perform the largest number of these operations of any surgical group in Chicago and in most cases use minimally invasive techniques that speed recovery.

21 Feb 2015

Proximity Ligation Assay helps detect effectiveness of cancer vaccines

Cancer vaccines are designed to turn the body's own immune system specifically against tumor cells. Particularly promising are vaccines that are directed against so-called neoantigens: These are proteins that have undergone a genetic mutation in tumor cells and, therefore, differ from their counterparts in healthy cells.

20 Feb 2015

New study turns to epigenetics to look for new therapeutic targets to treat allergic diseases

Scientists have discovered over 30 new genes that predispose people to allergies and asthma, some of which could be targets for new drugs.

20 Feb 2015

Scientists identify promising new therapeutic target for prostate cancer

Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth. The protein, GPR158, was found while the researchers were looking for new drug targets for glaucoma.

20 Feb 2015

Targeting pericytes and ANG2 signaling may help treat certain breast cancers

Tumors require blood to emerge and spread. That is why scientists at The University of Texas MD Anderson Cancer Center believe that targeting blood vessel cells known as pericytes may offer a potential new therapeutic approach when combined with vascular growth factors responsible for cell death.

19 Feb 2015

LBBC to host metastatic breast cancer conference in April 2015

Philadelphia-based Living Beyond Breast Cancer, the national information and support organization, has opened registration for its ninth annual conference for women living with metastatic breast cancer. The event takes place Saturday, April 11 – Sunday April 12, 2015 at the Loews Philadelphia Hotel in Philadelphia, Pennsylvania.

19 Feb 2015

Johns Hopkins study shows value follow-up PET/CT scans in patients with lung cancer

New research from Johns Hopkins School of Medicine reveals a high value of scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer. The study, featured in the February 2015 issue of the Journal of Nuclear Medicine, establishes the value of fourth and subsequent follow-up PET/CT scans in clinical assessment and management change in patients with the disease.

19 Feb 2015

Possible cause of liver disease identified in adolescents with cystic fibrosis

A professor at the University of Colorado School of Medicine at the Anschutz Medical Campus and his colleagues have found a possible cause of liver disease in adolescents with cystic fibrosis.

19 Feb 2015

Study findings could lead to new potential drug targets for allergic diseases

Scientists have discovered over 30 new genes that predispose people to allergies and asthma, some of which could be targets for new drugs.

19 Feb 2015

MD Anderson, CATCH Global Foundation partner to lower cancer risk in children

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings nationwide, to promote behavior that will lower children's lifelong risk of developing cancer.

19 Feb 2015

UT Southwestern scientists identify new biomarker that could optimize chemotherapy response

UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.

18 Feb 2015

Facts about precision medicine

President Barack Obama is requesting an increase of $215 million in the 2016 federal budget to launch the Precision Medicine Initiative. This boost in funding for research will give genetic causes of cancer a national focus specifically around precision or "personalized" treatments for cancer in the future.

18 Feb 2015

Lungs News and Research

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

Boehringer Ingelheim presents Phase III data for tiotropium at 2015 AAAAI Annual Meeting

Tobacco smoke exposure common among children with bronchopulmonary dysplasia

Finding opens avenues of research toward precision treatments to boost life expectancy for CF patients

Researchers develop targeted approach that allows muscle to burn more energy

MD Anderson awarded more than $22 million in research grants from CPRIT

Rush University Medical Center earns three-star rating for lung cancer surgery program

Proximity Ligation Assay helps detect effectiveness of cancer vaccines

New study turns to epigenetics to look for new therapeutic targets to treat allergic diseases

Scientists identify promising new therapeutic target for prostate cancer

Targeting pericytes and ANG2 signaling may help treat certain breast cancers

LBBC to host metastatic breast cancer conference in April 2015

Johns Hopkins study shows value follow-up PET/CT scans in patients with lung cancer

Possible cause of liver disease identified in adolescents with cystic fibrosis

Study findings could lead to new potential drug targets for allergic diseases

MD Anderson, CATCH Global Foundation partner to lower cancer risk in children

UT Southwestern scientists identify new biomarker that could optimize chemotherapy response

Facts about precision medicine

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News